| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $225.96K | $219.81K | $225.73K | $1.36M | $170.91K |
| R&D | – | – | – | – | – |
| SG&A | $225.96K | $219.81K | $225.73K | $1.36M | $170.91K |
| Operating Income | – | – | – | – | – |
| Interest Expense | $198.34K | $174.86K | $153.22K | $135.46K | $117.96K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$424.29K | -$394.67K | -$378.95K | -$1.49M | -$288.87K |
| EPS (basic) | -0.1700 | -0.1600 | -0.1500 | -0.6100 | -0.1200 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |